Transgenic mouse models of CMT1A overexpressing the human PMP22 (hPMP22) gene, including PMP22-C3 mice that contain 3–4 copies of hPMP22, have been widely used to elucidate disease mechanisms and facilitate drug discovery (21–23). This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.